Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd will become the largest shareholder in Chindex International Inc after it and private equity firm TPG said they would take the firm private in a $369 million deal. The deal would give Fosun and TPG access to China’s fast-growing private healthcare market, with the government keen to promote investment in the sector to support overburdened public hospitals and bring prices down through increased competition. China’s healthcare sector is estimated to hit $1 trillion by 2020, according to McKinsey & Company, but is bogged down by rampant corruption, skills shortages and fragmentation.
Help employers find you! Check out all the jobs and post your resume.
